The effect of newly designed dual-channel elastomeric pump for intravenous patient-controlled analgesia after total laparoscopic hysterectomy: a randomized, double-blind, prospective study

Seok Kyeong Oh, Heezoo Kim, Young Sung Kim, Chung Hun Lee, Jung Suk Oh, Dae Hui Kwon, Seok Kyeong Oh, Heezoo Kim, Young Sung Kim, Chung Hun Lee, Jung Suk Oh, Dae Hui Kwon

Abstract

Background: A newly designed intravenous patient-controlled analgesia (PCA) device with a dual-channel elastomeric infusion pump has been recently introduced. One channel is a continuous line with a constant flow rate basal infusion, while the other channel has an adjustable flow rate and bolus function and is labeled as a selector-bolus channel. This study compared dual and single-channel intravenous PCA in terms of clinical effect and quality of recovery.

Methods: Eighty-four patients undergoing total laparoscopic hysterectomy were randomly allocated to a 1-channel group (n = 41) or a 2-channel group (n = 43). Only the selector-bolus channel was utilized, but the continuous channel was not utilized in the 1-channel group, but both channels were utilized in the 2-channel group. In the 1-channel group, 16 μg/kg of fentanyl, 2 mg/kg of ketorolac, and 12 mg of ondansetron with normal saline were administered to the selector-bolus channel and normal saline only in the continuous channel for blinding. In the 2-channel group, 16 μg/kg of fentanyl was administered to the selector-bolus channel, and ketorolac (2 mg/kg) and ondansetron (12 mg) were administered via the continuous channel. The quality of recovery was evaluated preoperatively and 24 h postoperatively using the Quality of Recovery-40 (QoR-40). Cumulative PCA consumption, postoperative pain rated using the numeric rating scale (NRS; during rest/cough), and postoperative nausea were evaluated 6, 12, 24, 36, and 48 h after surgery. Incidence of vomiting and use of antiemetics and rescue analgesics was measured.

Results: The 24-h postoperative QoR-40 score was higher in the 2-channel group than in the 1-channel group (P=0.031). The incidence of nausea at 12 h and 36 h was significantly higher in the 1-channel group (P=0.043 and 0.040, respectively), and antiemetic use was more frequent in the 1-channel group (P=0.049). Patient satisfaction was higher in the 2-channel group (P=0.036). No significant differences were observed in pain scores during resting/cough or cumulative PCA consumption.

Conclusions: The 2-channel PCA showed better patient satisfaction with higher QoR-40 during the recovery compared with the 1-channel PCA. Better satisfaction was associated with lower nausea and reduced rescue antiemetics by maintaining the infusion of adjuvant analgesic agents and antiemetic agents constantly by utilizing dual channels.

Trial registration: Registered at ClinicalTrials.gov , NCT04082039 on 9 September 2019.

Keywords: Hysterectomy; Patient satisfaction; Patient-controlled analgesia; Postoperative nausea and vomiting; Quality of recovery.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Photograph of the Bellomic Duo® silicone balloon infuser
Fig. 2
Fig. 2
Schematic of the PCA device and its application. A In the 1-channel group, only the selector-bolus channel was actually utilized. B In the 2-channel group, both the selector-bolus channel and continuous channel were utilized by dividing the drugs between the two. The adjustable flow dial has a range of 0, 1, and 2 mL/h, but only 0 or 2 mL/h were used in both groups per our study protocol
Fig. 3
Fig. 3
A flowchart describing patient recruitment, randomization, and withdrawal
Fig. 4
Fig. 4
Violin plots of the global QoR-40 at preoperative period and preoperative 24 h. The change in the QoR-40 score from the preoperative period to the postoperative 24 h in the 1-channel group was significantly decreased, but not in the 2-channel group (P < 0.001 and P = 0.819, respectively, by the Wilcoxon signed-rank test). Abbreviations: QoR-40, quality of recovery-40 questionnaire

References

    1. Ballantyne JC, Carr DB, Chalmers TC, Dear KB, Angelillo IF, Mosteller F. Postoperative patient-controlled analgesia: meta-analyses of initial randomized control trials. J Clin Anesth. 1993;5:182–193. doi: 10.1016/0952-8180(93)90013-5.
    1. Beverly A, Kaye AD, Ljungqvist O, Urman RD. Essential elements of multimodal analgesia in Enhanced Recovery After Surgery (ERAS) Guidelines. Anesthesiol Clin. 2017;35:e115–e143. doi: 10.1016/j.anclin.2017.01.018.
    1. Bowen J, Levy N, Macintyre P. Opioid-induced ventilatory impairment: current ‘track and trigger’ tools need to be updated. Anaesthesia. 2020;75:1574–1578. doi: 10.1111/anae.15030.
    1. Chitnis SS, Tang R, Mariano ER. The role of regional analgesia in personalized postoperative pain management. Korean J Anesthesiol. 2020;73:363–371. doi: 10.4097/kja.20323.
    1. Choi KW, Nam KH, Lee JR, Chung WY, Kang SW, Joe YE, et al. The effects of intravenous lidocaine infusions on the quality of recovery and chronic pain after robotic thyroidectomy: a randomized, double-blinded, controlled study. World J Surg. 2017;41:1305–1312. doi: 10.1007/s00268-016-3842-1.
    1. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17:131–157. doi: 10.1016/j.jpain.2015.12.008.
    1. Chumbley GM, Hall GM, Salmon P. Why do patients feel positive about patient-controlled analgesia? Anaesthesia. 1999;54:386–389. doi: 10.1046/j.1365-2044.1999.00836.x.
    1. Du Manoir B, Aubrun F, Langlois M, Le Guern ME, Alquier C, Chauvin M, et al. Randomized prospective study of the analgesic effect of nefopam after orthopaedic surgery. Br J Anaesth. 2003;91:836–841.
    1. Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118:85–113. doi: 10.1213/ANE.0000000000000002.
    1. Grass JA. Patient-controlled analgesia. Anesth Analg. 2005;101:S44–S61. doi: 10.1213/01.ANE.0000177102.11682.20.
    1. Han L, Su Y, Xiong H, Niu X, Dang S, Du K, et al. Oxycodone versus sufentanil in adult patient-controlled intravenous analgesia after abdominal surgery: a prospective, randomized, double-blinded, multiple-center clinical trial. Medicine (Baltimore) 2018;97:e11552. doi: 10.1097/MD.0000000000011552.
    1. Hill RP, Lubarsky DA, Phillips-Bute B, Fortney JT, Creed MR, Glass PS, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000;92:958–967. doi: 10.1097/00000542-200004000-00012.
    1. Jung H, Lee KH, Jeong Y, Lee KH, Yoon S, Kim WH, et al. Effect of fentanyl-based intravenous patient-controlled analgesia with and without basal infusion on postoperative opioid consumption and opioid-related side effects: a retrospective cohort study. J Pain Res. 2020;13:3095. doi: 10.2147/JPR.S281041.
    1. Kim YS, Lee CH, Kim AR, Choi SS, Lee MK, Kim H, et al. Microbiological and physicochemical stability of fentanyl, oxycodone, hydromorphone, ketorolac, ramosetron, and ondansetron for intravenous patient-controlled analgesia: an in vitro study. Pain Physician. 2021;24:E829–Ee37. doi: 10.36076/ppj.2021.24.E829.
    1. Koh JC, Lee J, Kim SY, Choi S, Han DW. Postoperative pain and intravenous patient-controlled analgesia-related adverse effects in young and elderly patients: a retrospective analysis of 10,575 patients. Medicine (Baltimore) 2015;94:e2008. doi: 10.1097/MD.0000000000002008.
    1. Lee JH, Kim D, Seo D, Son JS, Kim DC. Validity and reliability of the Korean version of the Quality of Recovery-40 questionnaire. Korean J Anesthesiol. 2018;71:467–475. doi: 10.4097/kja.d.18.27188.
    1. Lee JW, Park HJ, Choi J, Park SJ, Kang H, Kim EG. Comparison of ramosetron's and ondansetron's preventive anti-emetic effects in highly susceptible patients undergoing abdominal hysterectomy. Korean J Anesthesiol. 2011;61:488–492. doi: 10.4097/kjae.2011.61.6.488.
    1. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999;89:652–658. doi: 10.1213/00000539-199909000-00022.
    1. Macintyre PE. Safety and efficacy of patient-controlled analgesia. Br J Anaesth. 2001;87:36–46. doi: 10.1093/bja/87.1.36.
    1. Murney P. To mix or not to mix–compatibilities of parenteral drug solutions. Aust Prescr. 2008;31:98–101. doi: 10.18773/austprescr.2008.057.
    1. Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000;84:11–15. doi: 10.1093/oxfordjournals.bja.a013366.
    1. Nielsen CK, Ross FB, Lotfipour S, Saini KS, Edwards SR, Smith MT. Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain. 2007;132:289–300. doi: 10.1016/j.pain.2007.03.022.
    1. Oh SK, Lee IO, Lim BG, Jeong H, Kim YS, Ji SG, et al. Comparison of the analgesic effect of sufentanil versus fentanyl in intravenous patient-controlled analgesia after total laparoscopic hysterectomy: a randomized, double-blind, prospective study. Int J Med Sci. 2019;16:1439–1446. doi: 10.7150/ijms.34656.
    1. Palmer PP, Miller RD. Current and developing methods of patient-controlled analgesia. Anesthesiol Clin. 2010;28:587–599. doi: 10.1016/j.anclin.2010.08.010.
    1. Parker RK, Holtmann B, White PF. Patient-controlled analgesia. Does a concurrent opioid infusion improve pain management after surgery? JAMA. 1991;266:1947–1952. doi: 10.1001/jama.1991.03470140059024.
    1. Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol. 2016;33:160–171. doi: 10.1097/EJA.0000000000000366.
    1. Reddy GS, Manjusruthi B, Jyothsna G. Postoperative nausea and vomiting prophylaxis: a comparative study of ramosetron and palonosetron in patients undergoing laparoscopic cholecystectomy - a prospective randomized trial. Anesth Essays Res. 2019;13:68–72. doi: 10.4103/aer.AER_192_18.
    1. Shin S, Min KT, Shin YS, Joo HM, Yoo YC. Finding the 'ideal' regimen for fentanyl-based intravenous patient-controlled analgesia: how to give and what to mix? Yonsei Med J. 2014;55:800–806. doi: 10.3349/ymj.2014.55.3.800.
    1. Sinatra R, Chung KS, Silverman DG, Brull SJ, Chung J, Harrison DM, et al. An evaluation of morphine and oxymorphone administered via patient-controlled analgesia (PCA) or PCA plus basal infusion in postcesarean-delivery patients. Anesthesiology. 1989;71:502–507. doi: 10.1097/00000542-198910000-00005.
    1. Tsui S, Irwin M, Wong C, Fung S, Hui T, Ng K, et al. An audit of the safety of an acute pain service. Anaesthesia. 1997;52:1042–1047. doi: 10.1111/j.1365-2044.1997.232-az0371.x.
    1. Walder B, Schafer M, Henzi I, Tramèr MR. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiol Scand. 2001;45:795–804. doi: 10.1034/j.1399-6576.2001.045007795.x.

Source: PubMed

3
Subscribe